Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) just released its latest first-quarter report and things are not looking great. It was a pretty negative result overall, with revenues of US$109m missing ...
Source LinkUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) just released its latest first-quarter report and things are not looking great. It was a pretty negative result overall, with revenues of US$109m missing ...
Source Link
Comments